Top Line

Moderna’s President Stephen Hoega said The COVID-19 booster shots targeting the Omicron version on Wednesday could be ready to submit to US authorization by March, though he and federal infectious disease point person Dr. Anthony Fauci both said they believe existing vaccines will be effective against the new strain, which Fauci is advising. The public will now get the booster.

important facts

- Advertisement -

Moderna has begun developing an Omicron-specific booster, Hoge told Reuters, as well as a multi-valent vaccine that targets Omicron and three other coronavirus variants, although that shot will take several more months.

The March target date is the earliest the Omicron booster can be approved under current U.S. Food and Drug Administration guidelines, although the company will manufacture the vaccine during the trial.

Hoge said he thinks existing vaccines “will be able to slow down if not completely discontinue the Omicron version.”

Fauci gave advice The public “boosted now,” in a press conference Wednesday morning, as “we may not need a type-specific boost,” though he said the Biden administration was about to develop a potential COVID-19 vaccine. Liaison with pharmaceutical companies. These boosters are needed.


- Advertisement -